FAT-SOLUBLE VITAMIN POWDER FOR FORTIFYING FOOD PRODUCTS

Abstract

The present invention relates to a formulation, which comprises a fat-soluble vitamin and which can be used for fortifying early life nutrition products.

Claims

1. A solid formulation comprising (i) at least one fat soluble vitamin, and (ii) at least one hydrocolloid, and (iii) at least one starch hydrolysate, and (iv) tocopherol, with the proviso that the formulation does not comprise any BHT, any ascorbic acid, any sodium ascorbate (an any other ascorbic acid salts), any ascorbyl palmitate (and any other ascorbyl esters), any BHA and any EMQ.

2. Solid formulation according to claim 1, wherein the at least one fat-soluble vitamin is chosen from the group consisting of vitamin A, vitamin D, Vitamin K and its derivatives thereof.

3. Solid formulation according to claim 1, wherein the at least one fat-soluble vitamin is chosen from the group consisting of vitamin A and derivatives thereof.

4. Solid formulation according to claim 1, wherein the content of the at least one fat-soluble vitamin is from 3 to 30 wt.-%, based on the total weight of the solid formulation.

5. Solid formulation according to claim 1, wherein the content of the at least one fat-soluble vitamin is from 5 to 25 wt.-%, based on the total weight of the solid formulation.

6. Solid formulation according to claim 1, wherein the at least one hydrocolloid is chosen from the group consisting of polysaccharides, gelatin of low bloom, medium bloom or high bloom from fish, pork or bovine, caseins/caseinates and other proteinaceous hydrocolloids.

7. Solid formulation according to claim 1, wherein the at least one hydrocolloid is chosen from the group consisting of xanthan gum, gum acacia, pectin, guar gum, caroub gum, alginates, celluloses, cellulose derivatives, such as starch and starch derivatives.

8. Solid formulation according to claim 1, wherein the content of the at least one hydrocolloid is 20 to 85 wt.-%, based on the total weight of the solid formulation.

9. Solid formulation according to claim 1, wherein the at least one starch hydrolysate is chosen from the group consisting of dextrins, maltodextrins and glucose syrup.

10. Solid formulation according to claim 1, wherein the content of the at least one starch hydrolysate is 10 to 60 wt.-%, based on the total weight of the solid formulation.

11. Solid formulation according to claim 1, wherein the content of the tocopherol is 0.1 to 5 wt.-%, based on the total weight of the solid formulation.

12. Solid formulation according to claim 1, wherein the water content of the solid formulation is below 5 wt-%, based on the total weight of the solid formulation.

13. Use of a solid formulation according to claim 1 to fortify early life nutrition (ELN) products.

14. Early life nutrition products fortified by a solid formulation according to claim 1.

Description

EXAMPLES

Example 1

[0106] A matrix solution was prepared by dissolving 180 g Hicap 100, 56 g Gum Acacia and 97 g Glucidex 19D in 222 g water at 65 C. while stirring. The pH of the solution was adjusted to 5.0 by adding 13.6 g of a 2M sodium acetate solution. 66 g vitamin A palmitate (1,7 MioIU/g) and 4.2 g mixed tocopherols (70IP) were mixed at 60 C. for 10 minutes and of this mixture 68.3 g was added to the matrix solution. The mixture was emulsified until the particle size D (0,5) was below 1 m as measured by Malvern Mastersizer 2000. The viscosity was adjusted by the addition of water and the emulsion was spray dried to yield 199 g dry powder with an LOD of 2.01%. The final dry powder had the composition of Exp. 1

[0107] The powder shown as Exp. 2 is produced according to example 1.

TABLE-US-00001 TABLE 1 Exp. 1 Exp. 2 Ingredients [wt-%] [wt-%] HiCap 100 43.9 29.3 Gum Acacia 13.7 4.9 Maltodextrin DE19 (Glucidex 19D) 23.7 47.1 Vitamin A Palmitate 15.7 15.6 Mixed Tocopherol 70IP 1.0 1.0 residual water 2.01 2.16

[0108] The powder shown as Exp. 3 is produced according to example 1. This is a comparative Example. This formulation comprises sodium ascorbate

TABLE-US-00002 TABLE 2 Exp. 3 (comparison Example) Ingredients [wt-%] Capsul HS 63.5 Maltodextrin DE2023 10.8 Sodium Ascorbate 1.0 Sodium Benzoate 0.6 Vitamin A Palmitate 16.2 MCT 5.0 tocopherol 70IP 2.9

Applications Tests

[0109] Stability of Vitamin A forms of the Examples were assessed in a typical infant formula vitamin premix with the final composition containing 3% of vitamin A product form, 46% lactose, 16% inositol, 16% taurine, 7% vit. E, 3% Vitamin D3, 2% Vitamin K1 and 7% of other ingredients (vit. B3, calcium, vit. B12, vit. B7, vit. B9, vit. B2, vit. B1 and vit. B6). Note that concentrations are given for the product forms.

[0110] For the blend preparation, 485 g of premix were filled in a 1 Litre glass bottle with 15 g of vitamin A product. Then the bottle content was mixed for 10 min at 22 rpm in an orbital mixer (Turbula, Type T2 C Shaker Mixer). The obtained mixture was then aliquoted in aluminium bags and stability studies of vitamin A palmitate were conducted at 30 C. up to 3 months. Initial determination of vitamin A content was performed in duplicate using 3 different bags with double measurement, whereas the following time points were based on duplicate measurement of 2 different bags.

TABLE-US-00003 TABLE 3 Stability data Ingredients 1 month 3 months Formulation of Exp. 1 100 81 Formulation of Exp. 2 100 98.5 Formulation of Exp. 3 100 58

[0111] It can be seen that the formulation according to the present invention show an improved stability.